FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lesniak Maciej

Research Profile

Disorders

Procedures

Living Beings

Chemicals & Drugs

Anatomy

Physiology

Devices

Drug Delivery Systems

Co-author Network

Publications

TOP 3
B Thaci; Ilya V Ulasov; Atique U Ahmed; S D Ferguson; Yu Han; Lesniak Maciej
Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation.
Alex Tobias; Kyung-Sub Moon; Atique Ahmed; Lesniak Maciej
The art of gene therapy for glioma: a review of the challenging road to the bedside.
Brenda Auffinger; Atique U Ahmed; Lesniak Maciej
Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lesniak Maciej (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: B Thaci; Ilya V Ulasov; Atique U Ahmed; S D Ferguson; Yu Han; Lesniak Maciej
Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation.
Gene therapy 2013;20(3):318-27.
2013: Alex Tobias; Kyung-Sub Moon; Atique Ahmed; Lesniak Maciej
The art of gene therapy for glioma: a review of the challenging road to the bedside.
Journal of neurology, neurosurgery, and psychiatry 2013;84(2):213-22.
2013: Brenda Auffinger; Atique U Ahmed; Lesniak Maciej
Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice.
Frontiers in oncology 2013;3():32.
2013: Ryan McDermott; Purvaba Sarvaiya; Ilya Ulasov; Patrik Gabikian; Lesniak Maciej
MicroRNAs in brain metastases: big things come in small packages.
Journal of molecular medicine (Berlin, Germany) 2013;91(1):5-13.
2012: B Thaci; A L Tobias; Ilya V Ulasov; Karen S Aboody; Atique U Ahmed; Yu Han; Lesniak Maciej
Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.
Cancer gene therapy 2012;19(6):431-42.
2011: Atique U Ahmed; Nikita G Alexiades; Yu Han; Bart Thaci; Matthew A Tyler; Ilya V Ulasov; Lesniak Maciej
A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.
Molecular pharmaceutics 2011;8(5):1559-72.
2011: Atique U Ahmed; Nikita G Alexiades; Irina V Balyasnikova; Yu Han; Feifei Liu; Shuo Qian; Bart Thaci; Ilya Y Ulasov; Karen S Aboody; Lesniak Maciej
Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.
Molecular therapy : the journal of the American Society of Gene Therapy 2011;19(9):1714-26.
2011: Atique U Ahmed; Lesniak Maciej
Glioblastoma multiforme: can neural stem cells deliver the therapeutic payload and fulfill the clinical promise?
Expert review of neurotherapeutics 2011;11(6):775-7.
2011: Mahua Dey; Ilya V Ulasov; Matthew A Tyler; Adam M Sonabend; Lesniak Maciej
Cancer stem cells: the final frontier for glioma virotherapy.
Stem cell reviews 2011;7(1):119-29.
2010: Atique U Ahmed; Nikita G Alexiades; Lesniak Maciej
The use of neural stem cells in cancer gene therapy: predicting the path to the clinic.
Current opinion in molecular therapeutics 2010;12(5):546-52.
2010: Atique U Ahmed; Cleo E Rolle; Matthew A Tyler; Yu Han; Sadhak Sengupta; Derek A Wainwright; Irina V Balyasnikova; Ilya V Ulasov; Lesniak Maciej
Bone marrow mesenchymal stem cells loaded with an oncolytic adenovirus suppress the anti-adenoviral immune response in the cotton rat model.
Molecular therapy : the journal of the American Society of Gene Therapy 2010;18(10):1846-56.
2009: Suvobroto Nandi; Ilya V Ulasov; Cleo E Rolle; Yu Han; Lesniak Maciej
A chimeric adenovirus with an Ad 3 fiber knob modification augments glioma virotherapy.
The journal of gene medicine 2009;11(11):1005-11.
2009: Justin Kranzler; Matthew A Tyler; Adam M Sonabend; Ilya V Ulasov; Lesniak Maciej
Stem cells as delivery vehicles for oncolytic adenoviral virotherapy.
Current gene therapy 2009;9(5):389-95.
2009: Matthew A Tyler; Ilya V Ulasov; Lesniak Maciej
Cancer cell death by design: apoptosis, autophagy and glioma virotherapy.
Autophagy 2009;5(6):856-7.
2009: Ilya V Ulasov; Adam M Sonabend; Suvobroto Nandi; Andrey Khramtsov; Yu Han; Lesniak Maciej
Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo.
British journal of cancer 2009;100(7):1154-64.
2009: Adam M Sonabend; Ilya V Ulasov; Yu Han; Cleo E Rolle; Suvobroto Nandi; D Cao; Matthew A Tyler; Lesniak Maciej
Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats.
Cancer gene therapy 2009;16(4):362-72.
2009: Ilya V Ulasov; Mathew A Tyler; Zeng B Zhu; Yu Han; Tong-Chuan He; Lesniak Maciej
Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy.
International journal of oncology 2009;34(3):729-42.
2009: Matthew A Tyler; Ilya V Ulasov; Adam M Sonabend; Suvobroto Nandi; Yu Han; S Marler; J Roth; Lesniak Maciej
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
Gene therapy 2009;16(2):262-78.
2009: Ronald W Mercer; Matthew A Tyler; Ilya V Ulasov; Lesniak Maciej
Targeted therapies for malignant glioma: progress and potential.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2009;23(1):25-35.
2008: Ilya V Ulasov; Matthew A Tyler; Angel A Rivera; Dirk M Nettlebeck; Joanne T Douglas; Lesniak Maciej
Evaluation of E1A double mutant oncolytic adenovectors in anti-glioma gene therapy.
Journal of medical virology 2008;80(9):1595-603.
2008: Suvobroto Nandi; Ilya V Ulasov; Matthew A Tyler; Adam Quasar Sugihara; Luciana Molinero; Yu Han; Zeng B Zhu; Lesniak Maciej
Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells.
Cancer research 2008;68(14):5778-84.
2008: Matthew A Tyler; Adam M Sonabend; Ilya V Ulasov; Lesniak Maciej
Vector therapies for malignant glioma: shifting the clinical paradigm.
Expert opinion on drug delivery 2008;5(4):445-58.
2008: Adam M Sonabend; Cleo E Rolle; Lesniak Maciej
The role of regulatory T cells in malignant glioma.
Anticancer research 2008;28(2B):1143-50.
2008: Adam M Sonabend; Ilya V Ulasov; Matthew A Tyler; Angel A Rivera; J Michael Mathis; Lesniak Maciej
Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma.
Stem cells (Dayton, Ohio) 2008;26(3):831-41.
2008: Adam M Sonabend; Simona Velicu; Ilya V Ulasov; Yu Han; Betty M. Tyler; Henry Brem; Majed M Matar; Jason G Fewell; Khursheed Anwer; Lesniak Maciej
A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma.
Anti-cancer drugs 2008;19(2):133-42.
2007: Lesniak Maciej
Advances in neuro-oncology: novel therapies and clinical trials.
Expert review of anticancer therapy 2007;7(12 Suppl):S1.
2007: Adam M Sonabend; Ilya V Ulasov; Lesniak Maciej
Emerging role of new transgenic mouse models in glioma research.
Expert review of anticancer therapy 2007;7(12 Suppl):S7-13.
2007: Adam M Sonabend; Karen Dana; Lesniak Maciej
Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma.
Expert review of anticancer therapy 2007;7(12 Suppl):S45-50.
2007: Ilya V Ulasov; Angel A Rivera; Dirk M Nettelbeck; Lisa B Rivera; J Michael Mathis; Adam M Sonabend; Matthew Tyler; Ming Wang; Joanne T Douglas; Lesniak Maciej
An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy.
International journal of oncology 2007;31(5):1177-85.
2007: Medina C Kushen; Adam M Sonabend; Lesniak Maciej
Current immunotherapeutic strategies for central nervous system tumors.
Surgical oncology clinics of North America 2007;16(4):987-1004, xii.
2007: Ilya V Ulasov; Angel A Rivera; Yu Han; David T Curiel; Zeng B Zhu; Lesniak Maciej
Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells.
Journal of neurosurgery 2007;107(3):617-27.
2007: Ilya V Ulasov; Zeng B Zhu; Matthew A Tyler; Yu Han; Angel A Rivera; Andrey Khramtsov; David T Curiel; Lesniak Maciej
Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.
Human gene therapy 2007;18(7):589-602.
2007: Abdeljabar El Andaloussi; Lesniak Maciej
CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas.
Journal of neuro-oncology 2007;83(2):145-52.
2007: Ilya V Ulasov; Angel A Rivera; Adam M Sonabend; Lisa B Rivera; Ming Wang; Zeng B Zhu; Lesniak Maciej
Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy.
Cancer biology & therapy 2007;6(5):679-85.
2007: Sherise Ferguson; Lesniak Maciej
Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors.
Current drug delivery 2007;4(2):169-80.
2007: Sophy Zheng; Ilya V Ulasov; Yu Han; Matthew A Tyler; Zeng B Zhu; Lesniak Maciej
Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
The journal of gene medicine 2007;9(3):151-60.
2007: Ilya V Ulasov; Matthew A Tyler; Yu Han; Joel N Glasgow; Lesniak Maciej
Novel recombinant adenoviral vector that targets the interleukin-13 receptor alpha2 chain permits effective gene transfer to malignant glioma.
Human gene therapy 2007;18(2):118-29.
2006: Abdeljabar El Andaloussi; Adam M Sonabend; Yu Han; Lesniak Maciej
Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors.
Glia 2006;54(6):526-35.
2006: Wael Musleh; Adam M Sonabend; Lesniak Maciej
Role of craniotomy in the management of pituitary adenomas and sellar/parasellar tumors.
Expert review of anticancer therapy 2006;6 Suppl 9():S79-83.
2006: Adam M Sonabend; Wael Musleh; Lesniak Maciej
Oncogenesis and mutagenesis of pituitary tumors.
Expert review of anticancer therapy 2006;6 Suppl 9():S3-14.
2006: Matthew A Tyler; Ilya V Ulasov; Anton Borovjagin; Adam M Sonabend; Andrey Khramtsov; Yu Han; Paul Dent; Paul B Fisher; David T Curiel; Lesniak Maciej
Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus.
Molecular cancer therapeutics 2006;5(9):2408-16.
2006: Abdeljabar El Andaloussi; Yu Han; Lesniak Maciej
Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors.
Journal of neurosurgery 2006;105(3):430-7.
2006: Abdeljabar El Andaloussi; Lesniak Maciej
An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme.
Neuro-oncology 2006;8(3):234-43.
2006: Ilya V Ulasov; Matthew A Tyler; Sophy Zheng; Yu Han; Lesniak Maciej
CD46 represents a target for adenoviral gene therapy of malignant glioma.
Human gene therapy 2006;17(5):556-64.
2006: Simona Velicu; Yu Han; Ilya V Ulasov; Ian E Brown; Abdeljabar El Andaloussi; Thomas F Gajewski; Lesniak Maciej
Cross-priming of T cells to intracranial tumor antigens elicits an immune response that fails in the effector phase but can be augmented with local immunotherapy.
Journal of neuroimmunology 2006;174(1-2):74-81.
2006: Lesniak Maciej
Gene therapy for malignant glioma.
Expert review of neurotherapeutics 2006;6(4):479-88.
2006: Lesniak Maciej
Immunotherapy for brain tumors: quo vadis?
Expert review of neurotherapeutics 2006;6(4):447-51.
2006: Winan J van Houdt; Yosef S Haviv; Baogen Lu; Minghui Wang; Angel A Rivera; Ilya V Ulasov; Martine L M Lamfers; Daniel T Rein; Lesniak Maciej; Gene P Siegal; Clemens M F Dirven; David T Curiel; Zeng B Zhu
The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma.
Journal of neurosurgery 2006;104(4):583-92.
2006: Adam M Sonabend; Ilya V Ulasov; Lesniak Maciej
Conditionally replicative adenoviral vectors for malignant glioma.
Reviews in medical virology 2006;16(2):99-115.
2006: Adam M Sonabend; Ilya V Ulasov; Yu Han; Lesniak Maciej
Oncolytic adenoviral therapy for glioblastoma multiforme.
Neurosurgical focus 2006;20(4):E19.
2006: Lesniak Maciej
Targeted therapy for malignant glioma: neural stem cells.
Expert review of neurotherapeutics 2006;6(1):1-3.
2005: Lesniak Maciej; Erin Kelleher; Drew M Pardoll; Yan Cui
Targeted gene therapy to antigen-presenting cells in the central nervous system using hematopoietic stem cells.
Neurological research 2005;27(8):820-6.
2005: Lesniak Maciej; Urvashi Upadhyay; Rory Goodwin; Betty M. Tyler; Henry Brem
Local delivery of doxorubicin for the treatment of malignant brain tumors in rats.
Anticancer research 2005;25(6B):3825-31.
2005: Joseph C Hsieh; Lesniak Maciej
Surgical management of high-grade gliomas.
Expert review of neurotherapeutics 2005;5(6 Suppl):S33-9.
2005: Adam M Sonabend; Lesniak Maciej
Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletions.
Expert review of neurotherapeutics 2005;5(6 Suppl):S25-32.
2005: Lesniak Maciej
Brain tumors: controversies and challenges in management.
Expert review of neurotherapeutics 2005;5(6 Suppl):1-2.
2005: Christian W Sikorski; Lesniak Maciej
Immunotherapy for malignant glioma: current approaches and future directions.
Neurological research 2005;27(7):703-16.
2005: Wesley Hsu; Lesniak Maciej; Betty M. Tyler; Henry Brem
Local delivery of interleukin-2 and adriamycin is synergistic in the treatment of experimental malignant glioma.
Journal of neuro-oncology 2005;74(2):135-40.
2005: Lesniak Maciej
Novel advances in drug delivery to brain cancer.
Technology in cancer research & treatment 2005;4(4):417-28.
2005: Sherise Ferguson; Lesniak Maciej
Percival Bailey and the classification of brain tumors.
Neurosurgical focus 2005;18(4):e7.
2004: Lesniak Maciej; Patrik Gabikian; Betty M. Tyler; Drew M Pardoll; Henry Brem
Dexamethasone mediated inhibition of local IL-2 immunotherapy is dose dependent in experimental brain tumors.
Journal of neuro-oncology 2004;70(1):23-8.
2004: Lesniak Maciej; Henry Brem
Targeted therapy for brain tumours.
Nature reviews. Drug discovery 2004;3(6):499-508.
2003: Lesniak Maciej; Jack M Klem; Jon D Weingart; Benjamin S Carson
Surgical outcome following resection of contrast-enhanced pediatric brainstem gliomas.
Pediatric neurosurgery 2003;39(6):314-22.
2003: Lesniak Maciej; Betty M. Tyler; Drew M Pardoll; Henry Brem
Gene therapy for experimental brain tumors using a xenogenic cell line engineered to secrete hIL-2.
Journal of neuro-oncology 2003;64(1-2):155-60.
2002: Lesniak Maciej; R E Clatterbuck; Daniele Rigamonti; Michael A. Williams
Low pressure hydrocephalus and ventriculomegaly: hysteresis, non-linear dynamics, and the benefits of CSF diversion.
British journal of neurosurgery 2002;16(6):555-61.
2002: Lesniak Maciej; Michael P Viglione; Jon D Weingart
Multicentric parenchymal xanthogranuloma in a child: case report and review of the literature.
Neurosurgery 2002;51(6):1493-8; discussion 1498.
2002: Michael P Viglione; Stephen Potter; Alan W Partin; Lesniak Maciej; Jonathan I Epstein
Should the diagnosis of benign prostatic hyperplasia be made on prostate needle biopsy?
Human pathology 2002;33(8):796-800.
2002: Lesniak Maciej; Tarik Tihan; Alessandro Olivi
Solitary central nervous system metastasis from acinic cell carcinoma of the parotid gland.
The Journal of otolaryngology 2002;31(1):38-41.
2001: Lesniak Maciej; R Langer; Henry Brem
Drug delivery to tumors of the central nervous system.
Current neurology and neuroscience reports 2001;1(3):210-6.
2000: Lesniak Maciej; Prakash Sampath; Francesco DiMeco; Michael P Viglione; Betty M. Tyler; Drew M Pardoll; Henry Brem
Comparative analysis of paracrine immunotherapy in experimental brain tumors.
Neurosurgical focus 2000;9(6):e4.